NDC 52937-001
Vascepa
Icosapent Ethyl
Vascepa is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Amarin Pharma Inc.. The primary component is Icosapent Ethyl.
| Product ID | 52937-001_21c3862a-0006-4668-aabf-e05383634bf3 |
| NDC | 52937-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Vascepa |
| Generic Name | Icosapent Ethyl |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-10-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202057 |
| Labeler Name | Amarin Pharma Inc. |
| Substance Name | ICOSAPENT ETHYL |
| Active Ingredient Strength | 1000 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 52937-001-04
4 CAPSULE in 1 BOTTLE (52937-001-04)
| Marketing Start Date | 2012-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 52937-001-04 [52937000104]
Vascepa CAPSULE
| Marketing Category | NDA |
| Application Number | NDA202057 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-10-01 |
NDC 52937-001-20 [52937000120]
Vascepa CAPSULE
| Marketing Category | NDA |
| Application Number | NDA202057 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-10-01 |
NDC 52937-001-21 [52937000121]
Vascepa CAPSULE
| Marketing Category | NDA |
| Application Number | NDA202057 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-10-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ICOSAPENT ETHYL | 1000 mg/1 |
OpenFDA Data
| SPL SET ID: | 9c1a2828-1583-4414-ab22-a60480e8e508 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Medicade Reported Pricing
52937000120 VASCEPA 1 GM CAPSULE
Pricing Unit: EA | Drug Type:
NDC Crossover Matching brand name "Vascepa" or generic name "Icosapent Ethyl"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52937-001 | Vascepa | icosapent ethyl |
| 52937-003 | Vascepa | icosapent ethyl |
| 52937-101 | Vascepa | icosapent ethyl |
| 63629-8247 | Vascepa | icosapent ethyl |
| 43598-267 | Icosapent | Icosapent Ethyl |
| 63629-9312 | Icosapent | Icosapent Ethyl |
| 0054-0508 | Icosapent Ethyl | Icosapent Ethyl |
| 0480-0126 | Icosapent Ethyl | Icosapent Ethyl |
| 0480-0127 | Icosapent Ethyl | Icosapent Ethyl |
| 60505-4033 | Icosapent Ethyl | Icosapent Ethyl |
| 63629-9311 | Icosapent Ethyl | Icosapent Ethyl |
| 72603-129 | Icosapent Ethyl | Icosapent Ethyl |
Trademark Results [Vascepa]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VASCEPA 86655265 5001304 Live/Registered |
Amarin Pharmaceuticals Ireland Limited 2015-06-08 |
 VASCEPA 85202744 4238272 Live/Registered |
Amarin Pharmaceuticals Ireland Limited 2010-12-21 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.